Browse treatments

…ble clinical outcomes for stage II/III NSCLC patients underwent neoadjuvant immunotherapy. Vβ24-1Jβ2-1 and Vβ29-1Jβ2-7 were mainly localized in non-exhau…

… an autologous CAR-T targeting CD70 in ccRCC, is expanded under OUTLAST™ conditioning to address the challenges of the solid tumor TME. OUTLAST™ cond…

…ent regimen with pulsed electrical field ablation combined with intra-tumoral immunotherapy injection.Methods Treatments were performed using computed tomography gui…

…fferent mouse tumor models, alone or in combination with ICI or therapeutic vaccination. The TME of treated mice was assessed with multispectral flow c…

…e the availability of treatment options including chemotherapy, androgen deprivation therapy, androgen receptor inhibitors, and novel immunotherapies, prost…

… 8 our device could enable a ‘continuous biopsy’ of response to immunotherapy.Acknowledgements This work was supported the Office of the Dire…

…on in oral corticosteroid requirement with no patient requiring mOCS for CEP after 1 year of treatment. These findings support the u…

…y simulation training. Twice daily prompts were included in the NIV care plan to support communication on weaning and clinical prog…

…acerbations in patients with chronic hypercapnic COPD receiving LT-NIV. This highlights the importance of actively screening for and m…

…ytics after drainage failure; Group 2 (post-Nov. 2021) received fibrinolytics early. Outcomes are listed in table 1.Results Group 1(n=36) and…

…n lesions treated with coil embolisation (OR 1.926, p = 0.166). Embolisation with vascular plugs was associated with less risk of recanalisa…

…Introduction Bronchial Thermoplasty (BT) is an available therapy for severe asthma. However, we are…